Quantitative Proteome and Phosphoproteome Profiling across Three Cell Lines Revealed Potential Proteins Relevant to Nasopharyngeal Carcinoma Metastasis
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study identified key proteins driving nasopharyngeal carcinoma (NPC) metastasis. Researchers found CRABP2, NACAD, and DPYSL3 significantly enhance cancer cell migration and invasion, offering new biomarker candidates.
Area Of Science
- Oncology
- Proteomics
- Molecular Biology
Background
- Nasopharyngeal carcinoma (NPC) metastasis is a major cause of mortality despite reduced overall death rates.
- Understanding the molecular mechanisms of NPC metastasis is crucial for developing targeted therapies.
Purpose Of The Study
- To identify novel protein biomarkers associated with NPC metastasis using proteomic and phosphoproteomic analyses.
- To investigate the role of specific proteins in NPC cell migration and invasion.
Main Methods
- Proteomic and phosphoproteomic analyses of NPC cell lines (SUNE1, 5-8F, 6-10B) using TMT-based quantification.
- Differential protein and phosphoprotein expression analysis.
- Gene knockdown experiments to assess the functional impact of identified proteins on cell migration and invasion.
Main Results
- Identified differentially regulated proteins (DRPs) and phosphoproteins (DRpPs) enriched in cancer metastasis pathways (e.g., cell migration, PPAR, PI3K).
- Eight key proteins (CRABP2, DNAJC15, NACAD, MYL9, DPYSL3, MAOA, MCAM, S100A2) significantly affected NPC cell migration/invasion.
- CRABP2, NACAD, and DPYSL3 were found to dramatically enhance these processes.
- DNAJC15 and NACAD are newly identified as metastasis-related proteins in NPC.
Conclusions
- Proteomic and phosphoproteomic approaches are effective for identifying NPC metastasis biomarker candidates.
- The study provides novel insights into the molecular mechanisms of NPC metastasis.
- Identified proteins, particularly CRABP2, NACAD, and DPYSL3, represent potential therapeutic targets for NPC metastasis.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
